Viewing Study NCT02062905


Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2026-01-08 @ 4:58 AM
Study NCT ID: NCT02062905
Status: COMPLETED
Last Update Posted: 2019-09-11
First Post: 2014-02-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis
Sponsor: Ocular Therapeutix, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Adverse Events Module Baseline Characteristics Module Participant Flow Module